Radiology world reacts to GE HealthCare’s blockbuster $2B deal to buy Intelerad
The radiology world is reacting to GE HealthCare’s blockbuster plans to purchase cloud software provider Intelerad.
Chicago imaging systems manufacturer GEHC said Nov. 20 it hopes to close the transaction by the first half of 2026, subject to regulatory approvals and other conditions. It will fund the purchase with cash on hand and proceeds from debt financing, moderately increasing leverage, according to Moody’s.
Radiology experts such as Amine Korchi, MD, a Swiss physician and GEHC stockholder, weighed in on what the mega merger means for medical imaging and the greater healthcare ecosystem. GE HealthCare is acquiring Montreal-headquartered Intelerad at roughly a 10x revenue multiple, which he believes is proof GEHC is “walking the talk on digital, cloud and AI.”
“They’re already leaders in the equipment that produces medical images, and now increasingly in the software that powers how clinicians use them,” Korchi wrote Friday on LinkedIn, pointing to the company’s recent acquisition of neuroradiology AI leader Icometrix as one example. “All of this points toward a real metamorphosis: from hardware manufacturer to vertically integrated solution provider,” he added later. “A one-stop shop for imaging. And importantly, one that is built for the future: digital, intelligent and cloud-native.”
Korchi believes GE HealthCare is trying to position itself as one of the most “AI-ready” imaging manufacturers. However, this comes with challenges, he added, highlighting previous obstacles when hardware companies such as Philips and Carestream sought to expand their software offerings. Often these two businesses require a “totally different know-how, talent pool, industry culture, velocity and business model,” he added.
“As an investor in AI and imaging software, I’m also excited to see valuations for mature radiology software companies now firmly in the 9-figure,” Korchi added. “I expect this trend to continue as adoption grows, evidence of value accumulates, and the provider community increasingly decides that AI and cloud are simply the norm.”
Morris Panner—Intelerad president and former CEO of Ambra Health, which it acquired in 2021—echoed some of the same sentiments. He cited one of his favorite business quotes, noting that "software businesses are not tech businesses, they are people businesses."
“In healthcare technology that is even more true. We are an extended part of the care team and view everything through that lens,” he wrote.
George Booth, a medical imaging IT market analyst with Signify Research, noted the immediate strategic value for GEHC lies in gaining a “rapid foothold on the fast-evolving outpatient imaging market.” He cited previous work from the U.K. research outfit, showing a wider global shift to outpatient care in an “aim to alleviate pressure on hospitals.”
“Notably, the acquisition also lands at a time of intensified competition within the segment, as an array of vendor types including imaging IT/teleradiology vendors, hyperscalers and providers themselves are all in the midst of making/having made plays,” Booth wrote on LinkedIn. “As such, it has never been as important for stakeholders to truly understand the market makeup of this segment, accounting for strategic trends and competitive dynamics at a country level.”
Manoj Kenkare, MBA—a life sciences leader with IBM and former managing director with consulting firm Accenture—labeled GEHC’s acquisition as a “strategic shift.” With it, the company is transitioning from a capital expenditure-heavy imaging hardware business to a high-margin, recurring SaaS-led diagnostic platform, “creating a cloud-first ecosystem that unifies hospital, ambulatory and teleradiology workflows.”
“This is a textbook platform expansion into a fragmented, high-retention market with sticky software economics, strong [annual recurring revenue] visibility, and significant roll-up potential,” he wrote on LinkedIn. “Intelerad’s outpatient footprint, radiology/cardiology workflow tools and clinical-trial imaging capabilities complement GE’s in-hospital dominance and unlock meaningful synergy drivers: seamless hospital-ambulatory integration, an enterprise AI-enablement layer for GE and third-party models, global commercial cross-sell leverage and scalable cloud architecture.”
Kenkare believes the deal positions GEHC as a “digital diagnostics consolidator” against Philips, Siemens Healthineers and emerging AI-first platforms from other companies.
“From a provider perspective, the integrated platform reduces workflow fragmentation, improves radiologist productivity, accelerates AI adoption and streamlines clinical trial imaging operations,” he wrote. “From a patient perspective, it enables faster and more accurate diagnoses, greater access to subspecialty reads in underserved regions, more consistent care across settings, and earlier detection of disease through AI-supported, interoperable imaging workflows.”
Private equity firm scores on sale
Meanwhile, London-based private equity firm Hg is touting its successful exit from owning Intelerad about five years after buying a majority stake.
The investment group was estimated to have poured about $500 million into Intelerad in January 2020, with unconfirmed sources placing the total value at $650 million. (Hg said it partnered with Ardan Equity on the original deal.) Fast-forward to today, and that figure has more than tripled, with GEHC paying approximately $2.3 billion in cash.
Hg estimated that, during its ownership tenure, Intelerad increased its revenues more than 3.5 times over, transforming it into one of the world’s leading enterprise imaging platforms. The radiology and cardiology vendor now serves about 1,500 global customers, supporting 230 million exams annually and managing 8 billion scans across its network.
“Our partnership with Intelerad has been an outstanding journey of innovation, growth and leadership in healthcare technology,” Hg Partners Hector Guinness and Laura Grattan said in a statement. “We are incredibly proud of what the team has achieved and are confident that joining GE HealthCare will allow Intelerad to continue expanding its impact on global healthcare delivery.”
More on Intelerad
Since acquiring a majority stake, Hg said it has supported Intelerad in pursuing product innovation, including the launch of InteleGence, the vendor’s artificial intelligence platform. The company also has executed eight strategic acquisitions since Hg took over, “substantially broadening its product suite into a comprehensive enterprise imaging platform” that also covers mammography, image exchange and storage. Acquisitions have included Radius and Heart Imaging Technologies in 2021 for undisclosed sums, fellow image management/VNA vendor Ambra Health for an estimated $250M in 2021 and cloud platform company Life Image for $500 million in 2022. Along the way, Intelerad also named a new CEO in 2023 and inked a $50 million deal with an unnamed Michigan system that same year.
The company was founded in 1999 after four college graduates—working in the imaging department at McGill University Health Center—discovered a problem. Storing and sharing scans was tedious and manual processes resulted in errors, according to Intelerad’s history page. They banded together to create a more accessible solution, which eventually evolved into Intelerad. Before the Hg takeover, the company also acquired Clario Medical for workflow orchestration and work list automation in 2018. PE firm TA Associates made its own growth equity investment in Intelerad in 2022.
The vendor has offices in both the U.S. and Canada and an estimated 600-plus employees working across four continents.
GE HealthCare’s side
For its part, GEHC said the purchase will help further its goal to triple cloud-based product offerings within the next three years. Intelerad’s significant presence in outpatient care complements GEHC’s focus on the hospital-based imaging side, with their combination creating a “more comprehensive, cloud first” offering.
GE HealthCare said scaling these offerings will allow it to broaden customer reach and deliver image storage across more care settings. The business model also will accelerate GEHC’s shift toward software as a service, “significantly increasing recurring revenue.” It estimated the outpatient enterprise imaging business segment is worth $2 billion-plus worldwide. Such cloud-based solutions are anticipated to grow at a double-digit rate in the medium term, driven by accelerating software-as-a-service adoption, procedure shifts to the outpatient side, and demand for integrated solution that can increase operating efficiencies.
GEHC estimated the first full year of owning Intelerad will generate $270 million, 90% of which is recurring revenue. Adjusted earnings (before interest, taxes, depreciation and amortization) margin will be more than 30%, it added. Intelerad’s revenues are growing in the low double-digit range annually and are expected to accelerate under GE HealthCare’s ownership. Upon closing the deal, GEHC expects the transaction to immediately be accretive to top line growth and adjusted earnings margins. The buyer said it expects the transaction to be slightly dilutive to adjusted earnings in the short term and will offset this with “cost efficiencies.” It expects a high single-digit return on invested capital by year 5.
Moody’s said the acquisition will moderately increase GEHC’s leverage, reducing its capacity for additional add-ons at the current level. However, the company will derive “earnings enhancements” and other strategic benefits, with its ratings outlook remaining unchanged.
Travis Steed of Bank of America Securities issued a hold rating on GEHC’s stock following news of the deal. He noted that adding Intelerad is expected to enhance GE HealthCare’s growth by 20 basis points while bringing a strong cloud solution to the company. It previously lacked in this area, and the acquisition also aligns with GEHC’s goals to significantly expand software offerings by 2028. Despite the high acquisition costs, recurring revenue and high margins from Intelerad’s products are seen as key benefits to GEHC in the long term, he added.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.